Sara Galimberti
University of Siena(IT)University of Pisa(IT)Azienda Ospedaliera Citta' della Salute e della Scienza di Torino(IT)Ospedale Santa Chiara(IT)Azienda Ospedaliera Universitaria Pisana(IT)
Publications by Year
Research Areas
Chronic Lymphocytic Leukemia Research, Chronic Myeloid Leukemia Treatments, Lymphoma Diagnosis and Treatment, Multiple Myeloma Research and Treatments, Acute Myeloid Leukemia Research
Most-Cited Works
- → Lentiviral Hematopoietic Stem Cell Gene Therapy in Patients with Wiskott-Aldrich Syndrome(2013)1,025 cited
- → Oral melphalan and prednisone chemotherapy plus thalidomide compared with melphalan and prednisone alone in elderly patients with multiple myeloma: randomised controlled trial(2006)808 cited
- → Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study(2020)551 cited
- → Bortezomib-Melphalan-Prednisone-Thalidomide Followed by Maintenance With Bortezomib-Thalidomide Compared With Bortezomib-Melphalan-Prednisone for Initial Treatment of Multiple Myeloma: A Randomized Controlled Trial(2010)425 cited
- → Efficacy and safety of once-weekly bortezomib in multiple myeloma patients(2010)381 cited
- → Aspirin, Warfarin, or Enoxaparin Thromboprophylaxis in Patients With Multiple Myeloma Treated With Thalidomide: A Phase III, Open-Label, Randomized Trial